Amoxicillin-Clavulanate 600mg/5mL Oral Suspension from Japan
Combination powder for oral suspension with amoxicillin and clavulanic acid (beta-lactamase inhibitor) for resistant infections like sinusitis. Still classified in HTS 3004.10.50.55 as primarily penicillin-based for oral suspension in therapeutic doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Declare clavulanate content accurately; ensure dual-API stability testing
• Pitfall: confusing with plain amoxicillin headings